Cargando…
Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study
BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional rela...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589433/ https://www.ncbi.nlm.nih.gov/pubmed/37814956 http://dx.doi.org/10.1161/STROKEAHA.123.042656 |
_version_ | 1785123790819164160 |
---|---|
author | Sleight, Emilie Stringer, Michael S. Clancy, Una Arteaga, Carmen Jaime Garcia, Daniela Hewins, Will Jochems, Angela C.C. Hamilton, Olivia K.L. Manning, Cameron Morgan, Alasdair G. Locherty, Rachel Cheng, Yajun Liu, Xiaodi Zhang, Junfang Hamilton, Iona Jardine, Charlotte Brown, Rosalind Sakka, Eleni Kampaite, Agniete Wiseman, Stewart Valdés-Hernández, Maria C. Chappell, Francesca M. Doubal, Fergus N. Marshall, Ian Thrippleton, Michael J. Wardlaw, Joanna M. |
author_facet | Sleight, Emilie Stringer, Michael S. Clancy, Una Arteaga, Carmen Jaime Garcia, Daniela Hewins, Will Jochems, Angela C.C. Hamilton, Olivia K.L. Manning, Cameron Morgan, Alasdair G. Locherty, Rachel Cheng, Yajun Liu, Xiaodi Zhang, Junfang Hamilton, Iona Jardine, Charlotte Brown, Rosalind Sakka, Eleni Kampaite, Agniete Wiseman, Stewart Valdés-Hernández, Maria C. Chappell, Francesca M. Doubal, Fergus N. Marshall, Ian Thrippleton, Michael J. Wardlaw, Joanna M. |
author_sort | Sleight, Emilie |
collection | PubMed |
description | BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional relationships. METHODS: Between 2018 and 2021 in Edinburgh, we recruited patients presenting with lacunar or cortical ischemic stroke, whom we characterized for SVD features. We measured CVR in subcortical gray matter, normal-appearing white matter, and white matter hyperintensity using 3T magnetic resonance imaging. We assessed cognition using Montreal Cognitive Assessment. Statistical analyses included linear regression models with CVR as outcome, adjusted for age, sex, and vascular risk factors. We reported regression coefficients with 95% CIs. RESULTS: Of 208 patients, 182 had processable CVR data sets (median age, 68.2 years; 68% men). Although the strength of association depended on tissue type, lower CVR in normal-appearing tissues and white matter hyperintensity was associated with larger white matter hyperintensity volume (B(NAWM)=−0.0073 [95% CI, −0.0133 to −0.0014] %/mm Hg per 10-fold increase in percentage intracranial volume), more lacunes (B(NAWM)=−0.00129 [95% CI, −0.00215 to −0.00043] %/mm Hg per lacune), more microbleeds (B(NAWM)=−0.00083 [95% CI, −0.00130 to −0.00036] %/mm Hg per microbleed), higher deep atrophy score (B(NAWM)=−0.00218 [95% CI, −0.00417 to −0.00020] %/mm Hg per score point increase), higher perivascular space score (B(NAWM)=−0.0034 [95% CI, −0.0066 to −0.0002] %/mm Hg per score point increase in basal ganglia), and higher SVD score (B(NAWM)=−0.0048 [95% CI, −0.0075 to −0.0021] %/mm Hg per score point increase). Lower CVR in normal-appearing tissues was related to lower Montreal Cognitive Assessment without reaching convention statistical significance (B(NAWM)=0.00065 [95% CI, −0.00007 to 0.00137] %/mm Hg per score point increase). CONCLUSIONS: Lower CVR in patients with SVD was related to more severe SVD burden and worse cognition in this cross-sectional analysis. Longitudinal analysis will help determine whether lower CVR predicts worsening SVD severity or vice versa. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12113543. |
format | Online Article Text |
id | pubmed-10589433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105894332023-10-22 Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study Sleight, Emilie Stringer, Michael S. Clancy, Una Arteaga, Carmen Jaime Garcia, Daniela Hewins, Will Jochems, Angela C.C. Hamilton, Olivia K.L. Manning, Cameron Morgan, Alasdair G. Locherty, Rachel Cheng, Yajun Liu, Xiaodi Zhang, Junfang Hamilton, Iona Jardine, Charlotte Brown, Rosalind Sakka, Eleni Kampaite, Agniete Wiseman, Stewart Valdés-Hernández, Maria C. Chappell, Francesca M. Doubal, Fergus N. Marshall, Ian Thrippleton, Michael J. Wardlaw, Joanna M. Stroke Original Contributions BACKGROUND: Cerebrovascular reactivity (CVR) is inversely related to white matter hyperintensity severity, a marker of cerebral small vessel disease (SVD). Less is known about the relationship between CVR and other SVD imaging features or cognition. We aimed to investigate these cross-sectional relationships. METHODS: Between 2018 and 2021 in Edinburgh, we recruited patients presenting with lacunar or cortical ischemic stroke, whom we characterized for SVD features. We measured CVR in subcortical gray matter, normal-appearing white matter, and white matter hyperintensity using 3T magnetic resonance imaging. We assessed cognition using Montreal Cognitive Assessment. Statistical analyses included linear regression models with CVR as outcome, adjusted for age, sex, and vascular risk factors. We reported regression coefficients with 95% CIs. RESULTS: Of 208 patients, 182 had processable CVR data sets (median age, 68.2 years; 68% men). Although the strength of association depended on tissue type, lower CVR in normal-appearing tissues and white matter hyperintensity was associated with larger white matter hyperintensity volume (B(NAWM)=−0.0073 [95% CI, −0.0133 to −0.0014] %/mm Hg per 10-fold increase in percentage intracranial volume), more lacunes (B(NAWM)=−0.00129 [95% CI, −0.00215 to −0.00043] %/mm Hg per lacune), more microbleeds (B(NAWM)=−0.00083 [95% CI, −0.00130 to −0.00036] %/mm Hg per microbleed), higher deep atrophy score (B(NAWM)=−0.00218 [95% CI, −0.00417 to −0.00020] %/mm Hg per score point increase), higher perivascular space score (B(NAWM)=−0.0034 [95% CI, −0.0066 to −0.0002] %/mm Hg per score point increase in basal ganglia), and higher SVD score (B(NAWM)=−0.0048 [95% CI, −0.0075 to −0.0021] %/mm Hg per score point increase). Lower CVR in normal-appearing tissues was related to lower Montreal Cognitive Assessment without reaching convention statistical significance (B(NAWM)=0.00065 [95% CI, −0.00007 to 0.00137] %/mm Hg per score point increase). CONCLUSIONS: Lower CVR in patients with SVD was related to more severe SVD burden and worse cognition in this cross-sectional analysis. Longitudinal analysis will help determine whether lower CVR predicts worsening SVD severity or vice versa. REGISTRATION: URL: https://www.isrctn.com; Unique identifier: ISRCTN12113543. Lippincott Williams & Wilkins 2023-10-10 2023-11 /pmc/articles/PMC10589433/ /pubmed/37814956 http://dx.doi.org/10.1161/STROKEAHA.123.042656 Text en © 2023 The Authors. https://creativecommons.org/licenses/by/4.0/Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Contributions Sleight, Emilie Stringer, Michael S. Clancy, Una Arteaga, Carmen Jaime Garcia, Daniela Hewins, Will Jochems, Angela C.C. Hamilton, Olivia K.L. Manning, Cameron Morgan, Alasdair G. Locherty, Rachel Cheng, Yajun Liu, Xiaodi Zhang, Junfang Hamilton, Iona Jardine, Charlotte Brown, Rosalind Sakka, Eleni Kampaite, Agniete Wiseman, Stewart Valdés-Hernández, Maria C. Chappell, Francesca M. Doubal, Fergus N. Marshall, Ian Thrippleton, Michael J. Wardlaw, Joanna M. Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title | Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title_full | Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title_fullStr | Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title_full_unstemmed | Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title_short | Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study |
title_sort | cerebrovascular reactivity in patients with small vessel disease: a cross-sectional study |
topic | Original Contributions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589433/ https://www.ncbi.nlm.nih.gov/pubmed/37814956 http://dx.doi.org/10.1161/STROKEAHA.123.042656 |
work_keys_str_mv | AT sleightemilie cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT stringermichaels cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT clancyuna cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT arteagacarmen cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT jaimegarciadaniela cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT hewinswill cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT jochemsangelacc cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT hamiltonoliviakl cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT manningcameron cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT morganalasdairg cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT lochertyrachel cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT chengyajun cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT liuxiaodi cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT zhangjunfang cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT hamiltoniona cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT jardinecharlotte cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT brownrosalind cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT sakkaeleni cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT kampaiteagniete cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT wisemanstewart cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT valdeshernandezmariac cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT chappellfrancescam cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT doubalfergusn cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT marshallian cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT thrippletonmichaelj cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy AT wardlawjoannam cerebrovascularreactivityinpatientswithsmallvesseldiseaseacrosssectionalstudy |